More States Find Variant; N.Y. Cases Reach Record: Virus Update Bloomberg 1/7/2021 Bloomberg News
(Bloomberg) Connecticut, Texas and Pennsylvania reported their first cases of the virus variant that helped trigger a U.K. lockdown amid concern that Covid-19 deaths in the U.S. are likely to maintain a near-record pace at least through January. Mounting hospitalizations are offsetting any positive effect from the halting start to inoculations.
New York, New Jersey, Florida and North Carolina are among states that reported daily records as Illinois became the fifth state to surpass 1 million infections. Fatalities in Arizona reached a high and those in California were just two deaths from the record set at the end of 2020.
More States Find Variant; N.Y. Cases Reach Record: Virus Update
Bloomberg 1/7/2021 Bloomberg News
(Bloomberg) Connecticut, Texas and Pennsylvania reported their first cases of the virus variant that helped trigger a U.K. lockdown amid concern that Covid-19 deaths in the U.S. are likely to maintain a near-record pace at least through January. Mounting hospitalizations are offsetting any positive effect from the halting start to inoculations.
New York, New Jersey, Florida and North Carolina are among states that reported daily records as Illinois became the fifth state to surpass 1 million infections. Fatalities in Arizona reached a high and those in California were just two deaths from the record set at the end of 2020.
Delays Over Pricing Hold Back India s Vital Vaccine Rollout Delays Over Pricing Hold Back India s Vital Vaccine Rollout On Sunday, Serum s billionaire Chief Executive Officer Adar Poonawalla said Indian officials have orally agreed to buy 100 million doses at a special price of 200 rupees a shot, below the about $4 to $5 price tag given to the U.K. government.
A health worker opens a deep freezer during a Covid-19 vaccine dry run in Delhi, Jan. 2.
Highlights
Officials have orally agreed to buy 100 million doses at Rs 200: Serum
Over 10 million people have been affected by the virus in India
As major countries like the U.S. and China race to vaccinate their populations with rapidly approved shots, tens of millions of doses prepared for India are sitting in storage despite having been authorized for use.
Delays over pricing holds back India’s vital Covid-19 vaccine rollout
The Indian government may be looking to put pressure on Serum to lower its prices,
(REUTERS)Premium
. Updated: 06 Jan 2021, 05:44 AM IST Bloomberg
New Delhi and Serum Institute of India have engaged in months of haggling behind closed doors and are yet to sign a formal supply agreement
That has left at least 70 million vaccine doses in limbo despite the urgent need in a country facing the world’s second-largest outbreak
Share Via
Read Full Story
As major countries like the U.S. and China race to vaccinate their populations with rapidly approved shots, tens of millions of doses prepared for India are sitting in storage despite having been authorized for use.